Zobrazeno 1 - 10
of 46
pro vyhledávání: '"T, Meirinhos"'
Autor:
A. C., Duarte, Gomes C., Marques, M., Correia, B., Mendes, C., Mazeda, F., Guimarães, J., Abelha-Aleixo, M., Guerra, da Costa R., Pereira, T., Meirinhos, M. J., Santos
Publikováno v:
ARP Rheumatology; Jul-Sep2024, Vol. 3 Issue 3, p182-188, 7p
Autor:
Mónica Eusébio, Elsa Vieira-Sousa, João Eurico Fonseca, Joana Silva, Maria José Santos, Rita Cruz-Machado, Daniela Santos-Faria, Miguel Bernardes, T. Meirinhos, Nikita Khmelinskii, C. Miguel, Pedro Avila-Ribeiro, Pedro Carvalho, P. Nero, Helena Santos, Ana Catarina Duarte, Tiago Costa, Teresa Martins Rocha
Publikováno v:
The Journal of rheumatology. 47(5)
Objective.To assess longterm effectiveness of tumor necrosis factor inhibitors (TNFi) in patients with psoriatic arthritis (PsA) registered in the Rheumatic Diseases Portuguese Register, exposed to at least 1 TNFi, prospectively followed between 2001
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76f95c7fb43d6b36db5f346bb4ea2c8c
https://pubmed.ncbi.nlm.nih.gov/31371659
https://pubmed.ncbi.nlm.nih.gov/31371659
Autor:
João Eurico Fonseca, Maria José Santos, Ana Rita Cruz-Machado, Daniela Faria, Pedro Ávila-Ribeiro, Lídia Teixeira, T. Meirinhos, Tiago Costa, Helena Santos, Cláudia Miguel, Elsa Vieira-Sousa, Pedro Carvalho, T. Martins-Rocha, Mónica Eusébio, Miguel Bernardes, P. Nero, Joana Silva, Nikita Khmelinskii
Publikováno v:
Saturday, 15 June 2019.
Background: The impact of gender on tumor necrosis factor inhibitors (TNFi) effectiveness has been poorly studied in Psoriatic Arthritis (PsA) patients. Objectives: To study gender differences in persistence and response of 1st TNFi in PsA patients.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cb47edb056e3a706adde72a555ccd72a
https://doi.org/10.1136/annrheumdis-2019-eular.4254
https://doi.org/10.1136/annrheumdis-2019-eular.4254
Autor:
Fernando Pimentel-Santos, J. Canas da Silva, R. Fonseca, Pedro Avila-Ribeiro, Helena Canhão, Maria João Salvador, Jaime Branco, Miguel Bernardes, D. van der Heijde, Marcos Cerqueira, Lídia Teixeira, Pedro D. Carvalho, Anabela Barcelos, Alexandre Sepriano, J. Borges, Elsa Vieira-Sousa, Josiane S. Neves, Sofia Ramiro, G. Sequeira, Robert Landewé, Helena Santos, T. Meirinhos
Publikováno v:
Arthritis & Rheumatology. 68:2671-2679
Objective To evaluate whether use of comedication with conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) influences the retention of tumor necrosis factor inhibitors (TNFi) in patients with spondyloarthritis (SpA). Methods Patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::10e6afde585e65e3311b21ff53b86219
https://doi.org/10.1002/art.39772
https://doi.org/10.1002/art.39772
Autor:
Heleodório Honorato dos Santos, Nikita Khmelinskii, J Leite Silva, T. Meirinhos, M. J. Santos, T Martins Rocha, P. Carvalho, P. Nero, Ana Rita Machado, C. Miguel, Daniela Santos-Faria, Mónica Eusébio, M. Bernardes, T. Costa, L. Teixeira, Elsa Vieira-Sousa, Pedro Ávila-Ribeiro
Publikováno v:
Psoriatic arthritis.
Background Tumour necrosis factor inhibitors (TNFi) lead to a dramatic improvement in the management of psoriatic arthritis (PsA). Nevertheless, a significant proportion of patients still do not respond and/or are intolerant to TNFis, requiring treat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1bac15e8dbd0e5bfccb37979715ef67d
https://doi.org/10.1136/annrheumdis-2018-eular.5998
https://doi.org/10.1136/annrheumdis-2018-eular.5998
Publikováno v:
Acta reumatologica portuguesa. 39(4)
The loss of muscle mass (MM) is a serious problem which has been demonstrated in patients with rheumatoid arthritis. There are few studies about the loss of MM in patients with spondyloarthritis (Spa).To assess muscle mass index (MMI) in a cohort of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a2e2b6227c95ab3dab66ad5df0003446
https://pubmed.ncbi.nlm.nih.gov/25584619
https://pubmed.ncbi.nlm.nih.gov/25584619
Autor:
Tamires Rocha, C. Miguel, T. Meirinhos, Ruana A. Machado, M. Bernardes, P. Nero, Pedro Ávila-Ribeiro, Pedro Carvalho, Mónica Eusébio, Nikita Khmelinskii, Daniela Santos-Faria, L. Teixeira, J Leite Silva, MJ Santos, T. Costa, Elsa Vieira-Sousa, Heleodório Honorato dos Santos
Publikováno v:
Value in Health. 20:A527
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::23d3990546587f59b418a2063b9e043d
https://doi.org/10.1016/j.jval.2017.08.727
https://doi.org/10.1016/j.jval.2017.08.727
Autor:
Fernando Pimentel-Santos, Lídia Teixeira, Maria João Salvador, Josiane S. Neves, Anabela Barcelos, T. Meirinhos, G. Sequeira, P. Άvila-Ribeiro, Robert Landewé, S. Ramiro, R. Fonseca, D. van der Heijde, J. Borges, Alexandre Sepriano, Pedro Carvalho, M. Bernardes, Helena Canhão, Marcos Cerqueira, Heleodório Honorato dos Santos, Elsa Vieira-Sousa, J. Canas da Silva, Jaime Branco
Publikováno v:
Annals of the Rheumatic Diseases. 75:97.1-97
Background The effects of comedication with conventional synthetic disease modifying antirheumatic drugs (csDMARDs) on TNF inhibitors (TNFi)-retention in spondyloarthritis (SpA), are inconclusive. Results from previous observational studies may have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ffc0939a327d257b6deecbe8021e3386
https://doi.org/10.1136/annrheumdis-2016-eular.1654
https://doi.org/10.1136/annrheumdis-2016-eular.1654
Autor:
D. Rosa-Gonçalves, R. Fonseca, Luiza Cesar Riani Costa, E. Mariz, Francisca Aguiar, T. Meirinhos, T. Martins-Rocha, M. Bernardes
Publikováno v:
Annals of the Rheumatic Diseases. 75:1121.1-1121
Background The 19809s ACR classification criteria for systemic sclerosis (SSc) show low sensitivity, especially in early or mild forms. A new set of classification criteria has been developed by ACR/EULAR in 2013. Applicability of the new criteria in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dfd98c99136caa99801de49219238403
https://doi.org/10.1136/annrheumdis-2016-eular.2435
https://doi.org/10.1136/annrheumdis-2016-eular.2435
Autor:
T. Meirinhos, Ricardo Neto, Etelvina Pereira, E. Mariz, I. Castro Ferreira, Luiza Cesar Riani Costa
Publikováno v:
Annals of the Rheumatic Diseases. 75:1052.1-1052
Background Systemic lupus erythematosus (SLE) is a multifaceted autoimmune disease driven by auto-reactive immune cells, in particular B cells that target multiple organ systems leading to severe complications. A main complication of SLE is nephritis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c927e9c2d686e859980545cfe5aecde8
https://doi.org/10.1136/annrheumdis-2016-eular.5961
https://doi.org/10.1136/annrheumdis-2016-eular.5961